Tag: API quality

Addressing Impurity Profile Drift Observed During Stability Studies to Prevent Batch Rejection and Recall The detection of impurity profile drift during stability studies poses a significant risk in pharmaceutical manufacturing,…

Assessing the Regulatory Impact of Impurity Profile Drift Observed in Stability Studies The detection of impurity profile drift during stability studies is a significant concern for pharmaceutical manufacturers and quality…

Investigating Impurity Profile Drift in Pharmaceutical Manufacturing: A Comprehensive Approach Detecting impurity profile drift during a deviation investigation can pose significant challenges for pharmaceutical manufacturers. This scenario raises critical questions…

Impacts of Particle Size Variability on Performance During Regulatory Inspections In the pharmaceutical manufacturing landscape, maintaining consistent quality throughout the production process is essential for regulatory compliance and product efficacy.…

Investigation of API Stability Failures During Stability Studies: Ensuring Compliance with GMP Expectations The pharmaceutical landscape is fraught with challenges around material quality, particularly concerning active pharmaceutical ingredients (API) during…

Framework for Investigating Impurity Profile Drift Detected During Regulatory Inspections Regulatory inspections often reveal critical insights into the quality of Active Pharmaceutical Ingredients (APIs) and their associated excipients. One such…

Mitigating API Assay Variability That Exceeds Trend Limits During Regulatory Inspections In the realm of pharmaceutical manufacturing, maintaining consistency and quality of Active Pharmaceutical Ingredients (APIs) is non-negotiable. Variability in…

Addressing API Assay Variability Beyond Trend Limits During a Deviation Investigation In pharmaceutical manufacturing, effective management of Active Pharmaceutical Ingredients (APIs) is crucial to maintaining product quality and regulatory compliance.…

Identifying and Addressing Impurity Profile Drift Following Supplier Changes In the dynamic environment of pharmaceutical manufacturing, changes to raw material suppliers can have significant impacts on product quality. One critical…

Understanding the Impact of Particle Size Variability on Incoming Testing Performance In the pharmaceutical manufacturing environment, ensuring the quality of raw materials, especially Active Pharmaceutical Ingredients (APIs) and excipients, is…

Understanding the Impact of Particle Size Variability During Supplier Changes Particle size variability can significantly affect the performance of Active Pharmaceutical Ingredients (APIs) and excipients, particularly during supplier changes. This…

Assessing Residual Solvent Excursions During Stability Investigations: A Comprehensive Guide Residual solvent excursions during stability studies can significantly impact the quality of active pharmaceutical ingredients (APIs) and subsequently affect regulatory…